Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) is established by institutions that use biological agents in research. The IBC is responsible for oversight of all aspects of the institution’s program for biological agent use in research conducted at or on behalf of Northwell Health. The IBC ensures that research involving these agents is conducted in a manner that protects researchers, laboratory personnel, human research subjects, the public and the environment ensuring compliance with the NIH Guidelines federal and state regulations, and institutional policies.

Northwell Health has two authorized IBCs registered with the National Institutes of Health (NIH) Office of Biotechnology Activities (OBA) – Office of Science Policy reviewing basic science, pre-clinical, and clinical research using biological agents. These committees also function as the Institutional Review Entity (IRE) for research considered Dual Use Research of Concern (DURC).

Research involving biological agents requires:

  • Registration and review by a health system authorized IBC and is conducted in accordance with determinations of the IBC; environmental, health and safety requirements; and other applicable requirements;
  • Review by an Institutional Review Entity (IRE) for select agents if covered under the U.S. Government Policy for Dual Use Research of Concern (DURC);
  • Training for all individuals involved in the conduct of the research, including those involved in the handling and management of biological agents.

Types of Biological Agents or Toxins Which Require Review by the IBC:

  • Recombinant and synthetic nucleic acid molecules
  • Potentially infectious or hazardous agents (bacteria, viruses, protozoans, fungi, prions, other microorganisms, and parasites)
  • Biological Toxins
  • Transgenic animals, invertebrates, and/or plants
  • Artificial Gene Transfer
  • Select Agents
  • Synthetic Biology
  • Dual Use Research of Concern (DURC)

See the IBC FAQs for information on:

  • Requirements for Participation in Biological Agents Research at Northwell Health
  • How to Submit IBC Registrations and Renewals
  • How to Take the Required Regulatory Training
  • How to Add New Personnel or Amend Responsibilities of Personnel

Quick Links:

Northwell Health IBC Meetings IBC Submission Deadlines
June 12, 2017
July 10, 2017
August 7, 2017
September 11, 2017
October 2, 2017
November 6, 2017
December 4, 2017
May 22, 2017
June 19, 2017
July 17, 2017
August 21, 2017
September 11, 2017
October 16, 2017
November 13, 2017

For questions regarding the Northwell Health IBC, please contact:
Michelle Aparicio, BS, CPIA
Director, IACUC & IBC
Research Administration
Phone: (516) 562-1274
IBC General Email: